Table 4.
Inhibitor Name | DPAP3 | DPAP1 | CatC | Specificity ratioa | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
k inact ·103 (s−1) | K i (nm) | k inact/K i ·10−3 (m −1·s−1) | k inact ·103 (s−1) | K i (nm) | k inact/K i ·10−3 (m −1·s−1) | k inact ·103 (s−1) | K i (nm) | k inact/K i ·10−3 (m −1·s−1) | DPAP1/DPAP3 | DPAP1/CatC | DPAP3/CatC | |
Pro‐hPhe‐VS | 3.5 ± 0.2 | 860 ± 100 | 4.1 ± 0.3 | 2.1 ± 0.2 | 4.6 ± 0.7 | 470 ± 35 | 1.45 ± 0.07 | 34 ± 5 | 42 ± 5 | 115 | 11 | 0.10 |
hPro‐hPhe‐VS | 2.1 ± 0.1 | 30 ± 7 | 69 ± 13 | 4.8 ± 0.6 | 3.9 ± 1.5 | 1230 ± 400 | 1.67 ± 0.08 | 22 ± 3 | 76 ± 0.8 | 18 | 16 | 0.91 |
hPro‐nLeu(o‐Bzl)‐VS | 2.0 ± 0.1 | 39 ± 6 | 53 ± 6.5 | 2.9 ± 0.3 | 0.8 ± 0.2 | 3560 ± 150 | 1.67 ± 0.03 | 11.2 ± 0.6 | 150 ± 6 | 68 | 24 | 0.35 |
Tyr(NO2)‐hPhe‐VS | 2.26 ± 0.05 | 2.4 ± 0.2 | 950 ± 74 | 3.8 ± 1 | 25 000 ± 1400 | 0.15 ± 0.05 | 3.2 ± 0.6 | 58 000 ± 20 000 | 0.054 ± 0.008 | 0.00016 | 2.8 | 17 600 |
Tyr(NO2)‐nLeu(o‐Bzl)‐VS | 2.7 ± 0.2 | 53 ± 10 | 51 ± 10 | 2.6 ± 0.3 | 2400 ± 900 | 1.1 ± 0.3 | 2.9 ± 0.2 | 7700 ± 1400 | 0.38 ± 0.05 | 0.032 | 2.9 | 89 |
2Nal‐hPhe‐VS | 2.59 ± 0.07 | 254 ± 16 | 10.2 ± 0.5 | 6.7 ± 0.2 | 33 000 ± 2000 | 0.2 ± 0.005 | 3.7 ± 0.2 | 4000 ± 700 | 0.9 ± 0.1 | 0.02 | 0.22 | 11 |
2Nal‐nLeu(o‐Bzl)‐VS | 6.0 ± 0.7 | 2800 ± 600 | 2.2 ± 0.3 | 5.0 ± 1.7 | 27 000 ± 16 000 | 0.19 ± 0.05 | 2.4 ± 0.6 | 1740 ± 140 | 1.37 ± 0.09 | 0.14 | 0.14 | 1.0 |
Igl‐hPhe‐VS | 2.1 ± 0.7 | 10 ± 1 | 205 ± 22 | 2.7 ± 0.1 | 5400 ± 500 | 0.50 ± 0.03 | 5.8 ± 0.3 | 320 ± 70 | 18 ± 3 | 0.0024 | 0.028 | 11.4 |
Igl‐nLeu(o‐Bzl)‐VS | 5.6 ± 0.4 | 160 ± 30 | 35 ± 4.5 | 4.1 ± 0.2 | 4800 ± 500 | 0.86 ± 0.05 | 1.48 ± 0.06 | 11 ± 2 | 135 ± 14 | 0.037 | 0.0064 | 0.17 |
L‐Trp‐hPG‐VS | 3 ± 1 | 330 ± 150 | 9.1 ± 1.5 | 2.1 ± 0.2 | 2800 ± 450 | 0.74 ± 0.07 | 1.73 ± 0.03 | 28 ± 2 | 61 ± 4 | 0.12 | 0.012 | 0.10 |
L‐Trp‐hPhe‐VS | 3.3 ± 0.4 | 65 ± 15 | 52 ± 7 | 1.7 ± 0.1 | 540 ± 80 | 3.20 ± 0.3 | 2.2 ± 0.09 | 16 ± 3 | 131 ± 15 | 0.094 | 0.024 | 0.26 |
L‐Trp‐nLeu(o‐Bzl)‐VS | 3.2 ± 0.3 | 4 ± 1 | 826 ± 193 | 2.2 ± 0.1 | 380 ± 60 | 5.8 ± 0.6 | 1.74 ± 0.03 | 4.9 ± 0.3 | 355 ± 18 | 0.0070 | 0.016 | 2.3 |
D‐Trp‐hPhe‐VS | 1.7 ± 0.6 | 5500 ± 3000 | 0.32 ± 0.08 | 2.7 ± 0.2 | 105 000 ± 10 000 | 0.026 ± 0.001 | 2.6 ± 0.1 | 4200 ± 600 | 0.62 ± 0.07 | 0.12 | 0.042 | 0.34 |
D‐Trp‐nLeu(o‐Bzl)‐VS | 3.6 ± 0.2 | 7600 ± 600 | 0.47 ± 0.01 | 5.5 ± 0.7 | 127 000 ± 20 000 | 0.044 ± 0.002 | 1.97 ± 0.06 | 1100 ± 100 | 1.7 ± 0.1 | 0.094 | 0.026 | 0.28 |
nVal‐hPhe‐VS | 2.6 ± 0.4 | 2.8 ± 0.9 | 940 ± 160 | 2.0 ± 0.1 | 0.6 ± 0.2 | 3160 ± 750 | 2.2 ± 0.1 | 0.38 ± 0.08 | 5830 ± 970 | 3.36 | 0.54 | 0.16 |
Specificity ratio was calculated based on k inact/K i values; numbers highlighted in bold indicate more than 100‐fold selectivity for the indicated enzymes. Standard error of the global fit for each parameter and inhibitor obtained by fitting k obs values (single replicate) to Eqs. 6 or 7 are shown.